17β-Estradiol modulates vasoconstriction induced by endothelin-1 following trauma-hemorrhage

Zheng F. Ba, Ailing Lu, Tomoharu Shimizu, László Szalay, Martin G Schwacha, Loring W. Rue, Kirby I. Bland, Irshad H. Chaudry

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Although endothelin-1 (ET-1) induces vasoconstriction, it remains unknown whether 17β-estradiol (E2) treatment following trauma-hemorrhage alters these ET-1-induced vasoconstrictive effects. In addition, the role of the specific estrogen receptor (ER) subtypes (ER-α and ER-β) and the endothelium-localized downstream mechanisms of actions of E2 remain unclear. We hypothesized that E2 attenuates increased ET-1-induced vasoconstriction following trauma-hemorrhage via an ER-β-mediated pathway. To study this, aortic rings were isolated from male Sprague-Dawley rats following trauma-hemorrhage with or without E2 treatment, and alterations in tension were determined in vitro. Dose-response curves to ET-1 were determined, and the vasoactive properties of E2, propylpyrazole triol (PPT, ER-α agonist), and diarylpropionitrile (DPN, ER-β agonist) were determined. The results showed that trauma-hemorrhage significantly increased ET-1-induced vasoconstriction; however, administration of E2 normalized ET-1-induced vasoconstriction in trauma-hemorrhage vessels to the sham-operated control level. The ER-β agonist DPN counteracted ET-1-induced vasoconstriction, whereas the ER-α agonist PPT was ineffective. Moreover, the vasorelaxing effects of E2 were not observed in endothelium-denuded aortic rings or by pretreatment of the rings with a nitric oxide (NO) synthase inhibitor. Cyclooxygenase inhibition with indomethacin had no effect on the action of E2. Thus, E2 administration attenuates ET-1-induced vasoconstriction following trauma-hemorrhage via an ER-β-mediated pathway that is dependent on endothelium-derived NO synthesis.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume292
Issue number1
DOIs
StatePublished - Jan 2007
Externally publishedYes

Fingerprint

Endothelin-1
Vasoconstriction
Estradiol
Hemorrhage
Estrogen Receptors
Wounds and Injuries
Estrogens
NAD
Endothelium
Prostaglandin-Endoperoxide Synthases
Nitric Oxide Synthase
Indomethacin
Sprague Dawley Rats
Nitric Oxide

Keywords

  • Aortic ring
  • Endothelium
  • Estrogen receptor
  • Nitric oxide

ASJC Scopus subject areas

  • Physiology

Cite this

17β-Estradiol modulates vasoconstriction induced by endothelin-1 following trauma-hemorrhage. / Ba, Zheng F.; Lu, Ailing; Shimizu, Tomoharu; Szalay, László; Schwacha, Martin G; Rue, Loring W.; Bland, Kirby I.; Chaudry, Irshad H.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 292, No. 1, 01.2007.

Research output: Contribution to journalArticle

Ba, Zheng F. ; Lu, Ailing ; Shimizu, Tomoharu ; Szalay, László ; Schwacha, Martin G ; Rue, Loring W. ; Bland, Kirby I. ; Chaudry, Irshad H. / 17β-Estradiol modulates vasoconstriction induced by endothelin-1 following trauma-hemorrhage. In: American Journal of Physiology - Heart and Circulatory Physiology. 2007 ; Vol. 292, No. 1.
@article{f4a0837c956840fe92498b759c5f9fb8,
title = "17β-Estradiol modulates vasoconstriction induced by endothelin-1 following trauma-hemorrhage",
abstract = "Although endothelin-1 (ET-1) induces vasoconstriction, it remains unknown whether 17β-estradiol (E2) treatment following trauma-hemorrhage alters these ET-1-induced vasoconstrictive effects. In addition, the role of the specific estrogen receptor (ER) subtypes (ER-α and ER-β) and the endothelium-localized downstream mechanisms of actions of E2 remain unclear. We hypothesized that E2 attenuates increased ET-1-induced vasoconstriction following trauma-hemorrhage via an ER-β-mediated pathway. To study this, aortic rings were isolated from male Sprague-Dawley rats following trauma-hemorrhage with or without E2 treatment, and alterations in tension were determined in vitro. Dose-response curves to ET-1 were determined, and the vasoactive properties of E2, propylpyrazole triol (PPT, ER-α agonist), and diarylpropionitrile (DPN, ER-β agonist) were determined. The results showed that trauma-hemorrhage significantly increased ET-1-induced vasoconstriction; however, administration of E2 normalized ET-1-induced vasoconstriction in trauma-hemorrhage vessels to the sham-operated control level. The ER-β agonist DPN counteracted ET-1-induced vasoconstriction, whereas the ER-α agonist PPT was ineffective. Moreover, the vasorelaxing effects of E2 were not observed in endothelium-denuded aortic rings or by pretreatment of the rings with a nitric oxide (NO) synthase inhibitor. Cyclooxygenase inhibition with indomethacin had no effect on the action of E2. Thus, E2 administration attenuates ET-1-induced vasoconstriction following trauma-hemorrhage via an ER-β-mediated pathway that is dependent on endothelium-derived NO synthesis.",
keywords = "Aortic ring, Endothelium, Estrogen receptor, Nitric oxide",
author = "Ba, {Zheng F.} and Ailing Lu and Tomoharu Shimizu and L{\'a}szl{\'o} Szalay and Schwacha, {Martin G} and Rue, {Loring W.} and Bland, {Kirby I.} and Chaudry, {Irshad H.}",
year = "2007",
month = "1",
doi = "10.1152/ajpheart.00809.2006",
language = "English (US)",
volume = "292",
journal = "American Journal of Physiology - Renal Physiology",
issn = "0363-6127",
publisher = "American Physiological Society",
number = "1",

}

TY - JOUR

T1 - 17β-Estradiol modulates vasoconstriction induced by endothelin-1 following trauma-hemorrhage

AU - Ba, Zheng F.

AU - Lu, Ailing

AU - Shimizu, Tomoharu

AU - Szalay, László

AU - Schwacha, Martin G

AU - Rue, Loring W.

AU - Bland, Kirby I.

AU - Chaudry, Irshad H.

PY - 2007/1

Y1 - 2007/1

N2 - Although endothelin-1 (ET-1) induces vasoconstriction, it remains unknown whether 17β-estradiol (E2) treatment following trauma-hemorrhage alters these ET-1-induced vasoconstrictive effects. In addition, the role of the specific estrogen receptor (ER) subtypes (ER-α and ER-β) and the endothelium-localized downstream mechanisms of actions of E2 remain unclear. We hypothesized that E2 attenuates increased ET-1-induced vasoconstriction following trauma-hemorrhage via an ER-β-mediated pathway. To study this, aortic rings were isolated from male Sprague-Dawley rats following trauma-hemorrhage with or without E2 treatment, and alterations in tension were determined in vitro. Dose-response curves to ET-1 were determined, and the vasoactive properties of E2, propylpyrazole triol (PPT, ER-α agonist), and diarylpropionitrile (DPN, ER-β agonist) were determined. The results showed that trauma-hemorrhage significantly increased ET-1-induced vasoconstriction; however, administration of E2 normalized ET-1-induced vasoconstriction in trauma-hemorrhage vessels to the sham-operated control level. The ER-β agonist DPN counteracted ET-1-induced vasoconstriction, whereas the ER-α agonist PPT was ineffective. Moreover, the vasorelaxing effects of E2 were not observed in endothelium-denuded aortic rings or by pretreatment of the rings with a nitric oxide (NO) synthase inhibitor. Cyclooxygenase inhibition with indomethacin had no effect on the action of E2. Thus, E2 administration attenuates ET-1-induced vasoconstriction following trauma-hemorrhage via an ER-β-mediated pathway that is dependent on endothelium-derived NO synthesis.

AB - Although endothelin-1 (ET-1) induces vasoconstriction, it remains unknown whether 17β-estradiol (E2) treatment following trauma-hemorrhage alters these ET-1-induced vasoconstrictive effects. In addition, the role of the specific estrogen receptor (ER) subtypes (ER-α and ER-β) and the endothelium-localized downstream mechanisms of actions of E2 remain unclear. We hypothesized that E2 attenuates increased ET-1-induced vasoconstriction following trauma-hemorrhage via an ER-β-mediated pathway. To study this, aortic rings were isolated from male Sprague-Dawley rats following trauma-hemorrhage with or without E2 treatment, and alterations in tension were determined in vitro. Dose-response curves to ET-1 were determined, and the vasoactive properties of E2, propylpyrazole triol (PPT, ER-α agonist), and diarylpropionitrile (DPN, ER-β agonist) were determined. The results showed that trauma-hemorrhage significantly increased ET-1-induced vasoconstriction; however, administration of E2 normalized ET-1-induced vasoconstriction in trauma-hemorrhage vessels to the sham-operated control level. The ER-β agonist DPN counteracted ET-1-induced vasoconstriction, whereas the ER-α agonist PPT was ineffective. Moreover, the vasorelaxing effects of E2 were not observed in endothelium-denuded aortic rings or by pretreatment of the rings with a nitric oxide (NO) synthase inhibitor. Cyclooxygenase inhibition with indomethacin had no effect on the action of E2. Thus, E2 administration attenuates ET-1-induced vasoconstriction following trauma-hemorrhage via an ER-β-mediated pathway that is dependent on endothelium-derived NO synthesis.

KW - Aortic ring

KW - Endothelium

KW - Estrogen receptor

KW - Nitric oxide

UR - http://www.scopus.com/inward/record.url?scp=33846192846&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846192846&partnerID=8YFLogxK

U2 - 10.1152/ajpheart.00809.2006

DO - 10.1152/ajpheart.00809.2006

M3 - Article

C2 - 17213481

AN - SCOPUS:33846192846

VL - 292

JO - American Journal of Physiology - Renal Physiology

JF - American Journal of Physiology - Renal Physiology

SN - 0363-6127

IS - 1

ER -